HUMA earnings: a positive outcome, +16.6%

On May 13, 2024, Humacyte, Inc. reached its earnings. The result was a positive outcome, and the stock moved +16.6% in the window around the event. It had already run +63.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.